The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

BRCA1-BARD1 constitutes a heterodimeric RING finger complex associated through its N-terminal regions. Here we demonstrate that the BRCA1-BARD1 heterodimeric RING finger complex contains significant ubiquitin ligase activity that can be disrupted by a breast cancer-derived RING finger mutation in BRCA1. Whereas individually BRCA1 and BARD1 have very low ubiquitin ligase activities in vitro, BRCA1 combined with BARD1 exhibits dramatically higher activity. Bacterially purified RING finger domains comprising residues 1–304 of BRCA1 and residues 25–189 of BARD1 are capable of polymerizing ubiquitin. The steady-state level of transfected BRCA1 in vivo was increased by co-transfection of BARD1, and reciprocally that of transfected BARD1 was increased by BRCA1 in a dose-dependent manner. The breast cancer-derived BARD1-interaction-deficient mutant, BRCA1C61G, does not exhibit ubiquitin ligase activity in vitro. These results suggest that the BRCA1-BARD1 complex contains a ubiquitin ligase activity that is important in prevention of breast and ovarian cancer development.

• Publication year

  2001

• Venue

  Journal of Biological Chemistry

• Publication date

  2001-05-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/JBC.C000881200PMID 11278247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases.

  2001cited by this paper
• Lessons learned from BRCA1 and BRCA2

  2000cited by this paper
• Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

  2000cited by this paper
• Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli.

  2000cited by this paper
• The ubiquitin system

  2000cited by this paper
• Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase

  2000cited by this paper
• Breast Cancer Genes and DNA Repair

  1999cited by this paper
• The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.

  1999cited by this paper
• Mapping the Functional Domains of BRCA1

  1999cited by this paper
• ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity.

  1999cited by this paper
• Activation of Transcription in Vitro by the BRCA1 Carboxyl-terminal Domain*

  1999cited by this paper
• Association with cullin partners protects ROC proteins from proteasome-dependent degradation

  1999cited by this paper
• Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34.

  1999cited by this paper
• RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.

  1999cited by this paper
• Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50.

  1999cited by this paper
• Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha.

  1999cited by this paper
• Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells.

  1999cited by this paper
• Recruitment of a ROC1–CUL1 Ubiquitin Ligase by Skp1 and HOS to Catalyze the Ubiquitination of IκBα

  1999cited by this paper
• Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase.

  1999cited by this paper
• Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.

  1998cited by this paper
• The ubiquitin system.

  1998cited by this paper
• SCF and APC: the Yin and Yang of cell cycle regulated proteolysis.

  1998cited by this paper
• The Cancer-predisposing Mutation C61G Disrupts Homodimer Formation in the NH2-terminal BRCA1 RING Finger Domain*

  1998cited by this paper
• BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases

  1997cited by this paper
• Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.

  1997cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper

• Multi-omics Characterization of Acquired Olaparib Resistance in BRCA1 and BRCA2 Mutant Breast Cancer Cell Lines

  2025cites this paper
• Navigating the Molecular and Cellular Landscape of Breast Cancer in India: From Unique Pathogenesis to the Promise of Personalized Medicine and Future Technologies

  2025cites this paper
• Dysregulated BARD1 Contributes to Paclitaxel Resistance in Ovarian Cancer via Up-regulating CYP2C8.

  2025cites this paper
• The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination

  2025cites this paper
• BARD1: A Friend or Foe in Pancreatic Ductal Adenocarcinoma?

  2025cites this paper
• Contribution of BARD1 gene to male breast cancer- report of a family with different types of cancer.

  2025cites this paper
• Domain-Specific DNA Binding Activities of BRCA1 Reveal Substrate Preferences for Homologous Recombination and Telomere Regulation

  2025cites this paper
• Low dose DNA methyltransferase inhibitors potentiate PARP inhibitors in homologous recombination repair deficient tumors

  2025cites this paper
• Distinct mechanisms of recognition of phosphorylated RNAPII C-terminal domain by BRCT repeats of the BRCA1–BARD1 complex

  2025cites this paper
• Predicting interaction-specific protein–protein interaction perturbations by missense variants with MutPred-PPI

  2025influential citation
• Pathogenic variants in MAEA disrupt DNA replication fork stability and are associated with developmental abnormalities in humans

  2025cites this paper
• Pathogenic BRCA1 mutations disrupt allosteric control by BARD1

  2025cites this paper
• Breast cancer gene-1 (BRCA1) potentiates maladaptive repair after kidney injury.

  2025cites this paper
• Hereditary Breast and Ovarian Cancer Syndromes

  2024cites this paper
• Current status and prospect of the DNA double-strand break repair pathway in colorectal cancer development and treatment.

  2024cites this paper
• Protein-folding chaperones predict structure-function relationships and cancer risk in BRCA1 mutation carriers

  2024cites this paper
• BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality

  2024cites this paper
• BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers

  2023cites this paper
• 53bp1 mutation enhances brca1 and bard1 embryonic lethality in C. elegans

  2023cites this paper
• Ubiquitinome Profiling Reveals in Vivo UBE2D3 Targets and Implicates UBE2D3 in Protein Quality Control

  2023cites this paper
• FIRRM cooperates with FIGNL1 to promote RAD51 disassembly during DNA repair

  2023cites this paper
• Double‐strand DNA break repair: molecular mechanisms and therapeutic targets

  2023cites this paper
• Protein-Folding Chaperones Predict Structure-Function Relationships and Cancer Risk in BRCA1 Mutation Carriers

  2023cites this paper
• BRCA1–BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes

  2023cites this paper
• Overcoming therapeutic resistance in pancreatic cancer: Emerging opportunities by targeting BRCAs and p53.

  2023cites this paper
• Molecular dynamics simulations reveal the effect of mutations in the RING domains of BRCA1-BARD1 complex and its relevance to the prognosis of breast cancer

  2023cites this paper
• The role of RING finger proteins in chromatin remodeling and biological functions.

  2023cites this paper
• R-Loops and R-Loop-Binding Proteins in Cancer Progression and Drug Resistance

  2023cites this paper
• Histone Tail Electrostatics Modulate E2-E3 Enzyme Dynamics: A Gateway to Regulate Ubiquitination Machinery

  2022cites this paper
• Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system.

  2022cites this paper
• XAF1 destabilizes estrogen receptor α through the assembly of a BRCA1-mediated destruction complex and promotes estrogen-induced apoptosis

  2022cites this paper
• BRCA1/BARD1 is a nucleosome reader and writer.

  2022cites this paper
• BRCA1 and DNA damage response

  2022cites this paper
• The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer

  2022cites this paper
• BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.

  2022cites this paper
• Differential requirement for BRCA1-BARD1 E3 ubiquitin ligase activity in DNA damage repair and meiosis in the Caenorhabditis elegans germ line

  2022cites this paper
• BRCA1 mediates protein homeostasis through the ubiquitination of PERK and IRE1

  2022cites this paper
• The Role of Protein Arginine Methyltransferases in DNA Damage Response

  2022cites this paper
• DNA binding and cleavage, BRCA1 gene interaction, antiglycation and anticancer studies of transition metal complexes of sulfonamides

  2022cites this paper
• Contribution of BRCA1 5382insC mutation to triplene-gative and luminal types of breast cancer in Ukraine

  2022cites this paper
• C1orf112 is a novel regulator of interstrand crosslink that decreases FIGNL1-RAD51 interaction

  2022cites this paper
• BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies

  2022cites this paper
• Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer

  2022cites this paper
• Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment

  2022cites this paper
• Hereditary Gynecological Malignancy and Molecular Features

  2021cites this paper
• Calcineurin regulates the stability and activity of estrogen receptor α

  2021cites this paper
• Functional evidence (II) protein and enzyme function

  2021cites this paper
• The emerging role of cellular post-translational modifications in modulating growth and productivity of recombinant Chinese hamster ovary cells.

  2021cites this paper
• BBIT20 inhibits homologous DNA repair with disruption of the BRCA1–BARD1 interaction in breast and ovarian cancer

  2021cites this paper
• BRCA1 degradation in response to mitochondrial damage in breast cancer cells

  2021cites this paper
• Effects of Silver Nanoparticles and Silver Nitrate on mRNA and microRNA Expression in Human Hepatocellular Carcinoma Cells (HepG2).

  2021cites this paper
• RNF13 Dileucine Motif Variants L311S and L312P Interfere with Endosomal Localization and AP-3 Complex Association

  2021cites this paper
• Homologous Recombination Deficiencies and Hereditary Tumors

  2021cites this paper
• Genetic Influences in Breast Cancer Drug Resistance

  2021cites this paper
• Differential Expression of BARD1 Isoforms in Melanoma

  2021cites this paper
• A synergetic effect of BARD1 mutations on tumorigenesis

  2021cites this paper
• Structural insights into DNA double-strand break signaling.

  2021cites this paper
• RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant

  2021cites this paper
• BARD1 Pathogenic Variants Are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort

  2021cites this paper
• UBC13 is an RNF213‐associated E2 ubiquitin‐conjugating enzyme, and Lysine 63‐linked ubiquitination by the RNF213‐UBC13 axis is responsible for angiogenic activity

  2021cites this paper
• Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population

  2021influential citation
• BRCA1-BARD1 regulates transcription through BRD4 in Xenopus nucleoplasmic extract

  2021cites this paper
• MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α

  2021cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• Molecular Characterization of U-box E3 Ubiquitin Ligases (TaPUB2 and TaPUB3) Involved in the Positive Regulation of Drought Stress Response in Arabidopsis

  2021cites this paper
• Mechanisms of BRCA1–BARD1 nucleosome recognition and ubiquitylation

  2021cites this paper
• The BRCA1/BARD1 ubiquitin ligase and its substrates.

  2021cites this paper
• SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation

  2021cites this paper
• OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation

  2021cites this paper
• Therapeutic Strategies to Target Activating Estrogen Receptor α Mutations

  2021cites this paper
• Ubiquitin Proteasome Pathway Transcriptome in Epithelial Ovarian Cancer

  2021cites this paper
• BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis

  2021cites this paper
• Post-translational modification of factors involved in homologous recombination.

  2021cites this paper
• Two redundant ubiquitin‐dependent pathways of BRCA1 localization to DNA damage sites

  2021cites this paper
• Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin.

  2021cites this paper
• L ARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis.

  2020cites this paper
• Identification of a novel mutations c.80 + 3del4 and *c.6589delA in Slovak HBOC families

  2020cites this paper
• Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers

  2020cites this paper
• BRCA1 in Centrosome Regulation

  2020cites this paper
• The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers

  2020cites this paper
• TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α

  2020cites this paper
• Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations

  2020cites this paper
• The Function of BARD1 in Centrosome Regulation in Cooperation with BRCA1/OLA1/RACK1

  2020cites this paper
• The implication of the SUMOylation pathway in breast cancer pathogenesis and treatment

  2020cites this paper
• Preparation and purification of mono-ubiquitinated proteins using Avi-tagged ubiquitin

  2020cites this paper
• BRCA1/BARD1 site-specific ubiquitylation of nucleosomal H2A is directed by BARD1

  2020cites this paper
• Identification of regulatory crosstalks between RKIP and BRCA1 tumor suppressors in healthy tissues and cancer (breast and ovarian): Therapeutic implications

  2020cites this paper
• The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication

  2020cites this paper
• RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma

  2020cites this paper
• PFKP is transcriptionally repressed by BRCA1/ZBRK1 and predicts prognosis in breast cancer

  2020cites this paper
• Functional analysis of BRCA1 RING domain variants: computationally derived structural data can improve upon experimental features for training predictive models.

  2020cites this paper
• p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability

  2020cites this paper
• The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders.

  2020cites this paper
• Structure-based functional analysis of BRCA1 RING domain variants: Concordance of computational mutagenesis, experimental assay, and clinical data.

  2020cites this paper
• The Biological Function and Therapeutic Potential of Exosomes in Cancer: Exosomes as Efficient Nanocommunicators for Cancer Therapy

  2020cites this paper
• BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis

  2020cites this paper
• LESSONS LEARNED FROM UNDERSTANDING CHEMOTHERAPY RESISTANCE IN EPITHELIAL TUBO-OVARIAN CARCINOMA FROM BRCA1 AND BRCA2 MUTATION CARRIERS.

  2020cites this paper
• Regulation of Histone Ubiquitination in Response to DNA Double Strand Breaks

  2020cites this paper
• PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB

  2020influential citation
• Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis

  2020cites this paper